Ordinatrix specializes in advanced proteomics through its innovative Nucleic Acid Programmable Protein Arrays (NAPPA) technology. This platform allows for the just-in-time production of proteins directly on microarrays, utilizing plasmid DNA to express proteins in situ. By employing human ribosomes and chaperone proteins, Ordinatrix ensures that the proteins are naturally folded and functionally active, which is critical for accurate biological analysis. The technology supports the display of over 18,000 unique human proteins, providing researchers with a customizable solution for studying protein interactions, functional activities, and other proteomic applications.

The NAPPA technology addresses several challenges associated with traditional protein microarray methods, such as the difficulties in protein purification and the variability in protein yields. By eliminating the need for extensive protein handling, NAPPA enhances reproducibility and stability, allowing for consistent protein levels across arrays. This approach not only simplifies the production process but also ensures high-quality protein arrays that are compatible with various immunoassays for verification. Ordinatrix's commitment to flexibility and precision in protein microarray technology positions it as a leader in the field, facilitating advancements in drug development, disease diagnosis, and personalized medicine.

United States

Discover the benefits of Nucleic Acid Programmable Protein Arrays(NAPPA).  The Ordinatrix team includes co-founders Prof. Josh LaBaer and Prof. Ji Qiu from Arizona State University, joined with biotech/life science executive Jim Hauert.  

Our goal is to be the leader in translational proteomics through the creation of the most functional, flexible, and precise protein microarrays in the industry based on our attention to quality, intellectual property, and many years of experience with the Nucleic Acid Programmable Protein Arrays (NAPPA) technology, which will aid in the development of new drugs, diagnosis of disease and approaches to personalized medicine.

Ordinatrix

Company Details